Abbott, Medtronic, Boston Scientific Corporation ... the market is segmented based on product type (drug-eluting stent (DES), ...

A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Boston Scientific has recently reported the results of the Optical Coherence Tomography Drug Eluting Stent Investigation (OCTDESI)trial; part of the JACTAX stent program. [30] The JACTAX stent con ...

The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...

Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference 6.4 Aug 08, 2024: Terumo India Launches Treo Abdominal Stent-graft System 6.5 Jun 13, 2024: Medtronic ...

Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference 6.4 Aug 08, 2024: Terumo India Launches Treo Abdominal Stent-graft System 6.5 Jun 13, 2024: Medtronic Confirms ...

The results in patients with long, complex lesions are better than or equal to those of surgery, but without the ...